CIK 0001588978 · Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260199180
- Phone
- 6502329832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-06 | Desai Antal Rohit Director | Sale 10b5-1 | −17,150 | $97.59 | $1.7M | 202,132 |
| 2024-11-06 | Desai Antal Rohit Director | Sale 10b5-1 | −3,769 | $98.29 | $370K | 198,363 |
| 2024-11-05 | Desai Antal Rohit Director | Other disposition 10b5-1 | −660,302 | 0 | ||
| 2024-11-05 | Desai Antal Rohit Director | Other disposition 10b5-1 | −172,016 | 0 | ||
| 2024-11-05 | Desai Antal Rohit Director | Other disposition 10b5-1 | −62,944 | 0 | ||
| 2024-11-05 | Desai Antal Rohit Director | Sale 10b5-1 | −7,566 | $95.38 | $722K | 256,797 |
| 2024-11-05 | Desai Antal Rohit Director | Sale 10b5-1 | −11,756 | $96.49 | $1.1M | 245,041 |
| 2024-11-05 | Desai Antal Rohit Director | Sale 10b5-1 | −11,487 | $97.17 | $1.1M | 233,554 |
| 2024-11-05 | Desai Antal Rohit Director | Sale 10b5-1 | −2,191 | $98.43 | $216K | 231,363 |
| 2024-10-30 | Zadno Reza President, CEO | Option exercise | +288,461 | $4.37 | $1.3M | 546,906 |
| 2024-10-30 | Zadno Reza President, CEO | Sale | −288,461 | $91.00 | $26.2M | 258,445 |
| 2024-10-30 | Zadno Reza President, CEO | Option exercise · Stock Option (Right to Buy) | −288,461 | 961,148 | ||
| 2024-10-15 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +25,000 | $4.56 | $114K | 121,096 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −15,959 | $72.11 | $1.2M | 105,137 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −8,115 | $73.02 | $593K | 97,022 |
| 2024-10-15 | Waters Kevin EVP, CFO | Sale 10b5-1 | −926 | $73.75 | $68K | 96,096 |
| 2024-10-15 | Waters Kevin EVP, CFO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 19,160 | ||
| 2024-09-16 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +15,917 | $4.52 | $72K | 112,013 |
| 2024-09-16 | Waters Kevin EVP, CFO | Option exercise 10b5-1 | +9,083 | $4.56 | $41K | 121,096 |
| 2024-09-16 | Waters Kevin EVP, CFO | Sale 10b5-1 | −6,623 | $81.96 | $543K | 114,473 |
Page 9 of 25 · 483 trades